Biote Corp BTMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $1.06
- Day Range
- $1.03–1.07
- 52-Week Range
- $0.99–2.90
- Bid/Ask
- $1.04 / $1.07
- Shares Outstanding
- 28.68M
- Market Cap
- $30.25M
- Volume/Avg
- 83,805 / 205,103
Key Statistics
- Price/Earnings (Normalized)
- 21.52
- Price/Sales
- 0.18
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 23.38%
Company Profile
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Value
- Total Number of Employees
- 223
- Website
- https://www.biote.com
Valuation
Metric | BTMD |
|---|---|
Price/Earnings (Normalized) | 21.52 |
Price/Book Value | — |
Price/Sales | 0.18 |
Price/Cash Flow | 2.51 |
Price/Earnings
BTMD
Financial Strength
Metric | BTMD |
|---|---|
Quick Ratio | 0.69 |
Current Ratio | 1.43 |
Interest Coverage | 2.10 |
Quick Ratio
BTMD
Profitability
Metric | BTMD |
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
BTMD
Medical Care Facilities Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| HCA Healthcare Inc HCA | LOCK|#pMg?Fs | LOCK|rG%<# | $103B | |||
| Fresenius SE & Co KGaA ADR FSNUY | — | LOCK|q&x#v | $33B | |||
| Fresenius SE & Co KGaA Registered Shares FSNUF | — | LOCK|y?kxs | $33B | |||
| Tenet Healthcare Corp THC | LOCK|Tm<c$b | LOCK|Mr?y | $23B | |||
| Encompass Health Corp EHC | — | LOCK|Wqjrj | $13B | |||
| Fresenius Medical Care AG FMCQF | — | LOCK|$JZF | $12B | |||
| Fresenius Medical Care AG ADR FMS | LOCK|@tL<#T | LOCK|Tv!^ | $12B | |||
| DaVita Inc DVA | LOCK|?$M@&x# | LOCK|@tg^^ | $12B | |||
| Universal Health Services Inc Class B UHS | LOCK|x@cX?l | LOCK|#?#! | $11B | |||
| Ensign Group Inc ENSG | — | LOCK|d&Pr | $11B |
United States